[Adoptive immunotherapy using MUC1--specific CTLs for unresectable pancreatic cancer].

MLA

Kawaoka, Toru, et al. “[Adoptive Immunotherapy Using MUC1--Specific CTLs for Unresectable Pancreatic Cancer].” Nihon Rinsho. Japanese Journal of Clinical Medicine, vol. 64 Suppl 1, Jan. 2006, pp. 279–82. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=16457266&authtype=sso&custid=ns315887.

APA

Kawaoka, T., Takashima, M., Yamamoto, K., Ueno, T., & Oka, M. (2006). [Adoptive immunotherapy using MUC1--specific CTLs for unresectable pancreatic cancer]. Nihon Rinsho. Japanese Journal of Clinical Medicine, 64 Suppl 1, 279–282.

Chicago

Kawaoka, Toru, Motonari Takashima, Koutaro Yamamoto, Tomio Ueno, and Masaaki Oka. 2006. “[Adoptive Immunotherapy Using MUC1--Specific CTLs for Unresectable Pancreatic Cancer].” Nihon Rinsho. Japanese Journal of Clinical Medicine 64 Suppl 1 (January): 279–82. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=16457266&authtype=sso&custid=ns315887.